• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿片类药物替代治疗药物滥用和转移的影响:证据综述与专家共识

The Impact of Misuse and Diversion of Opioid Substitution Treatment Medicines: Evidence Review and Expert Consensus.

作者信息

Reimer Jens, Wright Nat, Somaini Lorenzo, Roncero Carlos, Maremmani Icro, McKeganey Neil, Littlewood Richard, Krajci Peter, Alho Hannu, D'Agnone Oscar

机构信息

Centre for Interdisciplinary Addiction Research, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

出版信息

Eur Addict Res. 2016;22(2):99-106. doi: 10.1159/000438988. Epub 2015 Oct 2.

DOI:10.1159/000438988
PMID:26426530
Abstract

BACKGROUND/AIMS: Opioid substitution treatment (OST) improves outcomes in opioid dependence. However, controlled drugs used in treatment may be misused or diverted, resulting in negative treatment outcomes. This review defines a framework to assess the impact of misuse and diversion.

METHODS

A systematic review of published studies of misuse and diversion of OST medicines was completed; this evidence was paired with expert real-world experience to better understand the impact of misuse and diversion on the individual and on society.

RESULTS

Direct impact to the individual includes failure to progress in recovery and negative effects on health (overdose, health risks associated with injecting behaviour). Diversion of OST has impacts on a community that is beyond the intended OST recipient. The direct impact includes risk to others (unsupervised use; unintended exposure of children to diverted medication) and drug-related criminal behavior. The indirect impact includes the economic costs of untreated opioid dependence, crime and loss of productivity.

CONCLUSION

While treatment for opioid dependence is essential and must be supported, it is vital to reduce misuse and diversion while ensuring the best possible care. Understanding the impact of OST misuse and diversion is key to defining strategies to address these issues.

摘要

背景/目的:阿片类药物替代疗法(OST)可改善阿片类药物依赖的治疗效果。然而,治疗中使用的管制药物可能会被滥用或挪用,从而导致负面的治疗结果。本综述定义了一个框架,以评估滥用和挪用的影响。

方法

完成了对已发表的关于OST药物滥用和挪用研究的系统综述;该证据与专家的实际经验相结合,以更好地理解滥用和挪用对个人和社会的影响。

结果

对个人的直接影响包括康复进展受阻以及对健康的负面影响(过量用药、与注射行为相关的健康风险)。OST的挪用对社区产生的影响超出了预期的OST接受者范围。直接影响包括对他人的风险(无监督使用;儿童意外接触被挪用的药物)以及与毒品相关的犯罪行为。间接影响包括未治疗的阿片类药物依赖、犯罪和生产力损失的经济成本。

结论

虽然阿片类药物依赖的治疗至关重要且必须得到支持,但在确保提供最佳护理的同时减少滥用和挪用至关重要。了解OST滥用和挪用的影响是确定解决这些问题策略的关键。

相似文献

1
The Impact of Misuse and Diversion of Opioid Substitution Treatment Medicines: Evidence Review and Expert Consensus.阿片类药物替代治疗药物滥用和转移的影响:证据综述与专家共识
Eur Addict Res. 2016;22(2):99-106. doi: 10.1159/000438988. Epub 2015 Oct 2.
2
Supervised dosing with a long-acting opioid medication in the management of opioid dependence.在阿片类药物依赖管理中使用长效阿片类药物进行监督给药。
Cochrane Database Syst Rev. 2017 Apr 27;4(4):CD011983. doi: 10.1002/14651858.CD011983.pub2.
3
Addressing misuse and diversion of opioid substitution medication: guidance based on systematic evidence review and real-world experience.应对阿片类替代药物的滥用和转移:基于系统证据审查和实际经验的指南。
J Public Health (Oxf). 2016 Sep;38(3):e368-e374. doi: 10.1093/pubmed/fdv150. Epub 2015 Oct 27.
4
Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.针具交换计划和阿片类药物替代疗法预防注射吸毒者丙型肝炎传播
Cochrane Database Syst Rev. 2017 Sep 18;9(9):CD012021. doi: 10.1002/14651858.CD012021.pub2.
5
Sustained-release naltrexone for opioid dependence.用于阿片类药物依赖的缓释纳曲酮
Cochrane Database Syst Rev. 2025 May 9;5(5):CD006140. doi: 10.1002/14651858.CD006140.pub3.
6
Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation.美沙酮和丁丙诺啡用于阿片类药物依赖的管理:系统评价与经济学评估
Health Technol Assess. 2007 Mar;11(9):1-171, iii-iv. doi: 10.3310/hta11090.
7
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
8
Buprenorphine for managing opioid withdrawal.丁丙诺啡用于管理阿片类药物戒断。
Cochrane Database Syst Rev. 2017 Feb 21;2(2):CD002025. doi: 10.1002/14651858.CD002025.pub5.
9
Opioid agonist treatment for pharmaceutical opioid dependent people.用于药物性阿片类物质依赖者的阿片类激动剂治疗
Cochrane Database Syst Rev. 2016 May 9(5):CD011117. doi: 10.1002/14651858.CD011117.pub2.
10
Pain and Opioid Addiction: A Systematic Review and Evaluation of Pain Measurement in Patients with Opioid Dependence on Methadone Maintenance Treatment.疼痛与阿片类药物成瘾:对接受美沙酮维持治疗的阿片类药物依赖患者疼痛测量的系统评价与评估
Curr Drug Abuse Rev. 2016;9(1):49-60. doi: 10.2174/187447370901160321102837.

引用本文的文献

1
Challenges Faced and Coping Strategies Adopted by Injecting Drug Users during COVID-19 Lockdown-A Qualitative Study.新冠疫情封锁期间注射吸毒者面临的挑战及应对策略——一项定性研究
Indian J Community Med. 2023 Nov-Dec;48(6):846-851. doi: 10.4103/ijcm.ijcm_649_22. Epub 2023 Dec 1.
2
Supervised on-site dosing in injectable opioid agonist treatment-considering the patient perspective. Findings from a cross-sectional interview study in two German cities.在注射用阿片类激动剂治疗中进行监督现场给药——从患者角度出发。在德国两个城市进行的横断面访谈研究的结果。
Harm Reduct J. 2023 Nov 1;20(1):162. doi: 10.1186/s12954-023-00896-6.
3
Long-Acting Buprenorphine Formulations as a New Strategy for the Treatment of Opioid Use Disorder.
长效丁丙诺啡制剂作为治疗阿片类物质使用障碍的新策略
J Clin Med. 2023 Aug 26;12(17):5575. doi: 10.3390/jcm12175575.
4
Evaluating the feasibility of prolonged-release buprenorphine formulations as an alternative to daily opioid agonist therapy regardless of prior treatment adherence: a pilot study.评估长效丁丙诺啡制剂作为每日阿片类激动剂疗法替代方案的可行性,无论先前治疗依从性如何:一项试点研究。
Pilot Feasibility Stud. 2023 Jul 4;9(1):113. doi: 10.1186/s40814-023-01348-5.
5
Clients' experiences on North America's first take-home injectable opioid agonist treatment (iOAT) program: a qualitative study.客户对北美的首个家庭注射阿片类激动剂治疗(iOAT)项目的体验:一项定性研究。
BMC Health Serv Res. 2023 May 26;23(1):553. doi: 10.1186/s12913-023-09558-6.
6
Misuse of Over the Counter and Prescription Only Medication by Adults Accessing Specialist Treatment Services in the UK: A Narrative Synthesis.英国接受专科治疗服务的成年人滥用非处方药和处方药情况:一项叙述性综述
Subst Abuse. 2022 Jul 11;16:11782218221111833. doi: 10.1177/11782218221111833. eCollection 2022.
7
Risk of PTSD Due to the COVID-19 Pandemic Among Patients in Opioid Substitution Treatment.阿片类药物替代治疗患者中因新冠疫情感染患创伤后应激障碍的风险
Front Psychiatry. 2021 Sep 30;12:729460. doi: 10.3389/fpsyt.2021.729460. eCollection 2021.
8
The use of diverted pharmaceutical opioids is associated with reduced risk of fentanyl exposure among people using unregulated drugs in Vancouver, Canada.在加拿大温哥华,使用 diverted pharmaceutical opioids 与使用不受监管药物的人群中芬太尼暴露风险降低有关。
Drug Alcohol Depend. 2021 Nov 1;228:109109. doi: 10.1016/j.drugalcdep.2021.109109. Epub 2021 Sep 25.
9
Misuse of medication in adult substance misuse services: a systematic review protocol.成人物质滥用服务中药物滥用的误用:系统评价方案。
BMJ Open. 2021 Jun 22;11(6):e047283. doi: 10.1136/bmjopen-2020-047283.
10
Take home injectable opioids for opioid use disorder during and after the COVID-19 Pandemic is in urgent need: a case study.COVID-19大流行期间及之后用于阿片类物质使用障碍的居家注射用阿片类药物亟待解决:一项案例研究
Subst Abuse Treat Prev Policy. 2021 Mar 5;16(1):22. doi: 10.1186/s13011-021-00358-x.